Thrivent Financial For Lutherans Argenx Se Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Argenx Se stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 37,352 shares of ARGX stock, worth $21.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

37,352

Previous 36,788 1.53%

Holding current value

$21.1 Million

Previous $15.8 Million 27.99%

% of portfolio

0.04%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$434.22 - $551.9 $244,900 - $311,271	564 Added 1.53%	37,352 $20.2 Million
Q2 2024 Aug 13, 2024	SELL	$356.01 - $451.55 $1.92 Million - $2.43 Million	-5,384 Reduced 12.77%	36,788 $15.8 Million
Q1 2024 May 14, 2024	SELL	$356.95 - $413.29 $7.04 Million - $8.15 Million	-19,711 Reduced 31.85%	42,172 $16.6 Million
Q4 2023 Feb 14, 2024	SELL	$338.91 - $506.01 $2.43 Million - $3.63 Million	-7,183 Reduced 10.4%	61,883 $23.5 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $319,857 - $474,940	866 Added 1.27%	69,066 $34 Million
Q2 2023 Aug 14, 2023	SELL	$360.14 - $422.58 $3.23 Million - $3.79 Million	-8,957 Reduced 11.61%	68,200 $26.6 Million
Q1 2023 May 17, 2023	BUY	$334.23 - $403.65 $348,936 - $421,410	1,044 Added 1.37%	77,157 $28.7 Million
Q4 2022 Feb 08, 2023	SELL	$342.17 - $402.31 $199,827 - $234,949	-584 Reduced 0.76%	76,113 $28.8 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $372,372 - $429,388	-1,085 Reduced 1.39%	76,697 $27.1 Million
Q2 2022 Aug 16, 2022	SELL	$269.58 - $378.88 $1.25 Million - $1.75 Million	-4,623 Reduced 5.61%	77,782 $29.5 Million
Q1 2022 May 13, 2022	BUY	$254.45 - $351.06 $1.21 Million - $1.67 Million	4,745 Added 6.11%	82,405 $26 Million
Q4 2021 Feb 16, 2022	BUY	$272.01 - $353.03 $3.59 Million - $4.65 Million	13,183 Added 20.45%	77,660 $27.2 Million
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $7.07 Million - $8.4 Million	-23,959 Reduced 27.09%	64,477 $19.5 Million
Q2 2021 Aug 19, 2021	BUY	$257.11 - $319.92 $202,859 - $252,416	789 Added 0.9%	88,436 $26.6 Million
Q1 2021 May 17, 2021	SELL	$268.3 - $380.31 $1.92 Million - $2.73 Million	-7,168 Reduced 7.56%	87,647 $24.1 Million
Q4 2020 Feb 16, 2021	BUY	$248.13 - $308.36 $2.9 Million - $3.6 Million	11,682 Added 14.05%	94,815 $27.9 Million
Q3 2020 Nov 10, 2020	BUY	$215.51 - $272.51 $11.4 Million - $14.4 Million	52,904 Added 175.01%	83,133 $21.8 Million
Q2 2020 Aug 12, 2020	BUY	$127.44 - $232.72 $898,324 - $1.64 Million	7,049 Added 30.41%	30,229 $6.81 Million
Q1 2020 May 15, 2020	BUY	$108.83 - $165.23 $2.52 Million - $3.83 Million	23,180 New	23,180 $3.05 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Argenx Se Transaction History